1 |
Kaufman M, von Minckwitz G, Rody A. Preoperative (neoadjuvant) systemic therapy of breast cancer. Breast, 2005,14(6): 576-581.
|
2 |
Kooistra B, Wauters C, Strobbe L, et al. Preoperative cytological and histological diagnosis of breast lesions: A critical review. EJSO, 2010,36(10):934-940.
|
3 |
Jakesz R, Hausmaninger H, Samonigg H. Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer. Eur J Cancer, 2002,38(3):327-332.
|
4 |
Al Sarakbi W, Salhab M, Thomas V, et al. Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? Int Semin Surg Oncol, 2005,22(2):15.
|
5 |
Nadji M, Gomez-Fernandez C, Ganjei-Azar P, et al. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. Am J Clin Pathol 2005,123(1):21-27.
|
6 |
Rhodes A, Jasani B, Barnes DM, et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice:interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol, 2000,53(2):125-130.
|
7 |
Taucher S, Rudas M, Gnant M, et al. Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy. Endocr Relat Cancer, 2003,10(1):91-98.
|
8 |
Adams AL, Eltoum I, Krontiras H, et al. The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and HER2/neu status in breast carcinoma. Breast J, 2008, 14(2):141-146.
|
9 |
Tsuda H, Kurosumi M, Umemura S, et al. HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens. BMC Cancer, 2010,7(10):534.
|
10 |
Richter-Ehrenstein C, Müller S, Noske A, et al. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients. Int J Surg Pathol, 2009,17(4):323-326.
|
11 |
Ahill RA, Walsh D, Landers RJ, et al. Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy. Ann Surg Oncol, 2006,13(1):45-51.
|
12 |
Ough M, Velasco J, Hieken TJ. A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression. Am J Surg, 2010,17(9):685-687.
|